There are 2789 resources available
Discussion LBA12, 120MO and LBA13
Presenter: Marleen Kok
Session: Mini oral session - Breast cancer, early stage
Resources:
Slides
Webcast
Discussion LBA14, 121MO, 122MO and 123MO
Presenter: Véronique Diéras
Session: Mini oral session - Breast cancer, early stage
Resources:
Slides
Webcast
Discussion 1038MO and 1039MO
Presenter: Teresa Petrella
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Slides
Webcast
Discussion LBA39, LBA40 and 1041MO
Presenter: Teresa Troiani
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Slides
Webcast
Discussion LBA67 and 1743MO
Presenter: Laura Locati
Session: Mini oral session - NETs and endocrine tumours
Resources:
Slides
Webcast
Discussion 1099MO, 1100MO and 1101MO
Presenter: Chris Verslype
Session: Mini oral session - NETs and endocrine tumours
Resources:
Slides
Webcast
Discussion 515MO and 516MO
Presenter: Aung Naing
Session: Mini oral session - Developmental therapeutics
Resources:
Slides
Webcast
Discussion 517MO and 518MO
Presenter: Richard Schlenk
Session: Mini oral session - Developmental therapeutics
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Edward Garon
Session: Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated
Resources:
Slides
Webcast
Consistent with regimens appropriate for initial treatment of metastatic disease
Presenter: Federico Cappuzzo
Session: Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated
Resources:
Slides
Webcast